David L. Graham

4.4k total citations
95 papers, 3.0k citations indexed

About

David L. Graham is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, David L. Graham has authored 95 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 15 papers in Epidemiology. Recurrent topics in David L. Graham's work include Animal Virus Infections Studies (11 papers), Lung Cancer Treatments and Mutations (11 papers) and Bird parasitology and diseases (8 papers). David L. Graham is often cited by papers focused on Animal Virus Infections Studies (11 papers), Lung Cancer Treatments and Mutations (11 papers) and Bird parasitology and diseases (8 papers). David L. Graham collaborates with scholars based in United States, United Kingdom and Canada. David L. Graham's co-authors include W. L. Maxwell, John T. Povlishock, David N. Phalen, Van G. Wilson, Michael H. Ralphs, Lynn F. James, Merry Jennifer Markham, Danielle Gentile, B. W. Calnek and Robert M. Petitt and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

David L. Graham

91 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David L. Graham United States 30 609 603 544 417 348 95 3.0k
Christian Devaux France 44 379 0.6× 1.5k 2.5× 666 1.2× 438 1.1× 730 2.1× 184 7.4k
Shelley J. Newman United States 27 662 1.1× 235 0.4× 279 0.5× 297 0.7× 45 0.1× 111 2.6k
George Sourvinos Greece 36 534 0.9× 1.2k 2.0× 1.1k 2.1× 789 1.9× 93 0.3× 140 4.1k
Martin Wj United States 37 339 0.6× 1.5k 2.4× 1.8k 3.2× 736 1.8× 152 0.4× 280 5.9k
Colleen B. Jonsson United States 42 282 0.5× 1.9k 3.2× 1.0k 1.9× 199 0.5× 319 0.9× 166 6.9k
Yaping Chen China 29 220 0.4× 1.0k 1.7× 558 1.0× 627 1.5× 116 0.3× 183 3.9k
Andrew Pekosz United States 46 280 0.5× 2.0k 3.3× 3.1k 5.8× 324 0.8× 226 0.6× 198 7.7k
Satoshi Kaneko Japan 34 821 1.3× 374 0.6× 472 0.9× 595 1.4× 64 0.2× 148 3.2k
Rob C. Aalberse Netherlands 56 637 1.0× 1.9k 3.2× 893 1.6× 330 0.8× 194 0.6× 185 11.4k

Countries citing papers authored by David L. Graham

Since Specialization
Citations

This map shows the geographic impact of David L. Graham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Graham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Graham more than expected).

Fields of papers citing papers by David L. Graham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Graham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Graham. The network helps show where David L. Graham may publish in the future.

Co-authorship network of co-authors of David L. Graham

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Graham. A scholar is included among the top collaborators of David L. Graham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Graham. David L. Graham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Graham, David L., Penelope A. Bradbury, Martina Trinkaus, et al.. (2018). P1.01-54 A Phase I/Ib Study of Binimetinib (MEK162), a MEK Inhibitor Plus Carboplatin/Pemetrexed in Non-Squamous NSCLC. Journal of Thoracic Oncology. 13(10). S481–S482. 2 indexed citations
2.
Ross, Helen J., Steven E. Schild, Shauna L. Hillman, et al.. (2017). (S014) Long-Terms Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non-Small Cell Lung Cancer: NCCTG N0028 (Alliance). International Journal of Radiation Oncology*Biology*Physics. 98(2). E5–E5.
3.
Finelli, Antonio, Nofisat Ismaila, Jeremy C. Durack, et al.. (2017). Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology. 35(6). 668–680. 228 indexed citations
4.
Velagapudi, Poonam, et al.. (2011). Small Bowel Obstruction Due to Mycosis Fungoides: An Unusual Presentation. The American Journal of the Medical Sciences. 341(6). 508–509. 9 indexed citations
5.
Khaliq, Waseem, et al.. (2011). Ewing’s sarcoma: A case report of a 52-year-old woman with recurrent tumor and literature review. Oncology Letters. 3(1). 155–158. 4 indexed citations
6.
Traynor, Anne M., Ju-Whei Lee, Sachdev Thomas, et al.. (2009). A phase II trial of Triapine® (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503. Investigational New Drugs. 28(1). 91–97. 101 indexed citations
7.
Manock, Stephen R., et al.. (2008). Neurotoxic envenoming by South American coral snake (Micrurus lemniscatus helleri): case report from eastern Ecuador and review. Transactions of the Royal Society of Tropical Medicine and Hygiene. 102(11). 1127–1132. 48 indexed citations
8.
Graham, David L., et al.. (2004). In vitro papillomavirus capsid assembly analyzed by light scattering. Virology. 325(2). 320–327. 91 indexed citations
9.
10.
Marks, Randolph S., David L. Graham, Jeff A. Sloan, et al.. (2003). . American Journal of Clinical Oncology. 26(4). 336–337. 6 indexed citations
11.
Marks, Randolph S., David L. Graham, Jeff A. Sloan, et al.. (2003). A Phase II Study of the Dolastatin 15 Analogue LU 103793 in the Treatment of Advanced Non–Small-Cell Lung Cancer. American Journal of Clinical Oncology. 26(4). 336–337. 31 indexed citations
12.
Friedenberg, William R., et al.. (2003). The treatment of multiple myeloma with docetaxel (an ECOG study). Leukemia Research. 27(8). 751–754. 15 indexed citations
13.
Marsh, John C., Paul J. Catalano, Jie Huang, et al.. (2002). Eastern Cooperative Oncology Group Phase II Trial (E4296) of Oral 5-Fluorouracil and Eniluracil as a 28-Day Regimen in Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 2(1). 43–50. 10 indexed citations
14.
Raidal, Shane, GM CROSS, Elizabeth K. Tomaszewski, David L. Graham, & David N. Phalen. (1998). A serologic survey for avian polyomavirus and Pacheco's disease virus in Australian cockatoos. Avian Pathology. 27(3). 263–268. 8 indexed citations
15.
16.
Ralphs, Michael H., David L. Graham, Lynn F. James, & Kip E. Panter. (1994). Locoweed effects on a calf crop.. UA Campus Repository (The University of Arizona). 16(1). 35–37. 5 indexed citations
17.
Díez‐Martín, José L., David L. Graham, Robert M. Petitt, & Gordon W. Dewald. (1991). Chromosome Studies in 104 Patients With Polycythemia Vera. Mayo Clinic Proceedings. 66(3). 287–299. 108 indexed citations
18.
Teare, J. Andrew, Wayne S. Schwark, Sang J. Shin, & David L. Graham. (1985). Pharmacokinetics of a long-acting oxytetracycline preparation in ring-necked pheasants, great horned owls, and Amazon parrots. American Journal of Veterinary Research. 46(12). 2639–2643. 13 indexed citations
19.
Randolph, John F., N. Sydney Moïse, David L. Graham, & Christopher J. Murphy. (1984). Bacterial endocarditis and thromboembolism of a pelvic limb in an emu. Journal of the American Veterinary Medical Association. 185(11). 1409–1410. 9 indexed citations
20.
Martin, Charles L. & David L. Graham. (1977). Osteochondrosis in Swine. Journal of Chemical Education. 39(2). 2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Devaux Breakdown of academic impact, for papers by Shelley J. Newman Breakdown of academic impact, for papers by George Sourvinos Breakdown of academic impact, for papers by Martin Wj Breakdown of academic impact, for papers by Colleen B. Jonsson Breakdown of academic impact, for papers by Yaping Chen Breakdown of academic impact, for papers by Andrew Pekosz Breakdown of academic impact, for papers by Satoshi Kaneko Breakdown of academic impact, for papers by Rob C. Aalberse
Rankless by CCL
2026